A former Merck & Co. Inc. Inc. (NYSE:MRK) financial analyst pled guilty in New York federal court on 19 February to giving a Bank of New York Mellon Corp. manager illegal stock tips about pharmaceutical industry mergers in exchange for cash. On Friday shares of Merck & Co. Inc. (NYSE:MRK) closed at $58.35. Company’s sales growth for last 5 years was 9.00% and EPS growth for next 5 years is recorded as 5.46%.
Country Style Cooking Restaurant Chain Co., Ltd (NYSE: CCSC) announced that it plans to release its unaudited fourth quarter and fiscal year 2014 financial results on Wednesday, March 4, 2015, before the market opens. Country Style Cooking Restaurant Chain Co., Ltd. (NYSE:CCSC) in last trading activity fell -2.36% to close at $4.13. Company weekly performance is -6.14% while its quarterly performance stands at -24.77%. Country Style Cooking Restaurant Chain Co., Ltd. (NYSE:CCSC) is -66.40% away from its 52 week high.
On last trading day BioAmber Inc. (NYSE:BIOA) fell -2.15% to close at $9.09. Its volatility for the week is 3.65% while volatility for the month is 5.58%. BIOA’s sales growth for past 5 years was 55.20% and its EPS growth for past 5 years was 14.00%. BioAmber Inc. (NYSE:BIOA) monthly performance is 16.99%.
On 19 February, XenoPort, Inc. (NASDAQ:XNPT) announced its financial results for the fourth quarter and year ended December 31, 2014. Revenues for the fourth quarter were $7.1 million compared to $2.9 million for the same period in 2013. Net loss for the fourth quarter was $17.7 million compared to a net loss of $19.1 million for the fourth quarter of 2013. At December 31, 2014, XenoPort had cash and cash equivalents and short-term investments of $102.1 million. Xenoport, Inc. (NASDAQ:XNPT) has 1.10% insider ownership while its institutional ownership stands at 92.60%. In last trading activity company’s stock closed at $7.19.
On 16 February, AstraZeneca PLC (NYSE:AZN) said that it has received disappointing news when the U.S. District Court for the District of New Jersey said that the patent (Patent No. 7,524,834) protecting Pulmicort Respules in the U.S. is invalid. The drug is approved for the treatment of asthma. AstraZeneca PLC (NYSE:AZN) on Friday closed at $68.58. Stock institutional ownership is 6.90%. AstraZeneca PLC (NYSE:AZN) distance from 50-day simple moving average (SMA50) is -0.06%.